Skip to main content

Pliant Therapeutics, Inc.

PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746473

No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Pliant Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
134
−1 vs. Q3 2023
Shares held
62.7M
+5.57M (+9.7%) vs. Q3 2023
Total value
$1.14B
+$144.9M (+14.6%) vs. Q3 2023
New holders
19
53 more added
Sold out
20
33 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 134 institutions
Q1 2021: 76 institutionsQ2 2021: 81 institutionsQ3 2021: 77 institutionsQ4 2021: 88 institutionsQ1 2022: 92 institutionsQ2 2022: 88 institutionsQ3 2022: 110 institutionsQ4 2022: 125 institutionsQ1 2023: 143 institutionsQ2 2023: 144 institutionsQ3 2023: 136 institutionsQ4 2023: 134 institutionsQ1 2024: 135 institutionsQ2 2024: 144 institutionsQ3 2024: 151 institutionsQ4 2024: 161 institutionsQ1 2025: 141 institutionsQ2 2025: 114 institutionsQ3 2025: 100 institutionsQ4 2025: 98 institutionsQ1 2026: 91 institutionsQ2 2026: 86 institutions
Value heldQ4 2023: $1.14B
Q1 2021: $1.21BQ2 2021: $893.6MQ3 2021: $512.8MQ4 2021: $416.5MQ1 2022: $222.1MQ2 2022: $241.5MQ3 2022: $948.1MQ4 2022: $864.1MQ1 2023: $1.50BQ2 2023: $1.05BQ3 2023: $1.04BQ4 2023: $1.14BQ1 2024: $971.3MQ2 2024: $687.2MQ3 2024: $710.6MQ4 2024: $852.6MQ1 2025: $78.5MQ2 2025: $59.7MQ3 2025: $74.7MQ4 2025: $57.0MQ1 2026: $62.5MQ2 2026: $54.8M
Institutions holding PLRX and their total value by quarter
QuarterHoldersValue
Q2 202686$54.8M
Q1 202691$62.5M
Q4 202598$57.0M
Q3 2025100$74.7M
Q2 2025114$59.7M
Q1 2025141$78.5M
Q4 2024161$852.6M
Q3 2024151$710.6M
Q2 2024144$687.2M
Q1 2024135$971.3M
Q4 2023134$1.14B
Q3 2023136$1.04B
Q2 2023144$1.05B
Q1 2023143$1.50B
Q4 2022125$864.1M
Q3 2022110$948.1M
Q2 202288$241.5M
Q1 202292$222.1M
Q4 202188$416.5M
Q3 202177$512.8M
Q2 202181$893.6M
Q1 202176$1.21B

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Pliant Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding PLRX in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG342,173$6.20M0.00%+71,369+26.4%Added
AXA S.A.347,100$6.29M0.02%−8,397−2.4%Reduced
Barclays PLC352,897$6.39M0.00%+108,631+44.5%Added
Ameriprise Financial Inc369,801$6.70M0.00%−2,326−0.6%Reduced
Rock Springs Capital Management LP384,996$6.97M0.17%−106,225−21.6%Reduced
Goldman Sachs Group Inc387,246$7.01M0.00%+222,132+134.5%Added
Morgan Stanley405,023$7.33M0.00%+311,020+330.9%Added
Fernwood Investment Management, LLC423,177$7.66M2.53%+43,475+11.4%Added
Charles Schwab Investment Management Inc424,196$7.68M0.00%+5,990+1.4%Added
Candriam Luxembourg S.C.A.453,000$8.20M0.06%+138,000+43.8%Added
Northern Trust Corp505,326$9.15M0.00%+370+0.1%Added
Bessemer Group Inc532,079$9.64M0.02%00.0%Unchanged
Capital International Investors912,467$16.5M0.00%00.0%Unchanged
Deutsche Bank AG984,992$17.8M0.01%−577−0.1%Reduced
Granahan Investment Management Inc1,150,766$20.8M0.69%+211,557+22.5%Added
Geode Capital Management, LLC1,187,198$21.5M0.00%+60,984+5.4%Added
Ra Capital Management, L.P.1,281,000$23.2M0.36%−481,000−27.3%Reduced
Pictet Asset Management Holding SA1,318,804$23.9M0.03%+417,514+46.3%Added
State Street Corp1,335,278$24.2M0.00%+17,477+1.3%Added
Casdin Capital, LLC1,577,108$28.6M2.82%00.0%Unchanged
Citadel Advisors LLC1,578,514$28.6M0.03%+58,436+3.8%Added
Franklin Resources Inc1,579,572$28.6M0.01%+62,173+4.1%Added
Great Point Partners LLC1,823,184$33.0M5.63%+68,000+3.9%Added
Polar Capital Holdings Plc2,015,000$36.5M0.25%+350,000+21.0%Added
TRV GP IV, LLC2,132,867$38.6M15.69%00.0%Unchanged
Redmile Group, LLC2,696,648$48.8M1.75%+18,549+0.7%Added
Blue Owl Capital Holdings LP3,004,199$54.4M13.01%+3,004,199New
Vanguard Group Inc3,065,869$55.5M0.00%+120,557+4.1%Added
Laurion Capital Management LP3,583,567$64.9M2.33%+397,056+12.5%Added
First Light Asset Management, LLC3,591,776$65.0M5.23%+658,516+22.4%Added
Price T Rowe Associates Inc3,785,916$68.6M0.01%+434,429+13.0%Added
FMR LLC3,963,418$71.8M0.01%−177,586−4.3%Reduced
BlackRock Inc.4,801,517$87.0M0.00%+478,916+11.1%Added
Deep Track Capital, LP5,750,000$104.1M3.65%+250,000+4.5%Added
First Manhattan Co0$00.00%−370,200−100.0%Sold out
VR Adviser, LLC0$00.00%−288,949−100.0%Sold out
Millennium Management LLC0$00.00%−181,884−100.0%Sold out
Polar Asset Management Partners Inc.0$00.00%−124,000−100.0%Sold out
Two Sigma Investments, LP0$00.00%−102,709−100.0%Sold out
Jump Financial, LLC0$00.00%−78,768−100.0%Sold out
Marshall Wace, LLP0$00.00%−73,921−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−62,941−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−48,999−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−45,587−100.0%Sold out
Trexquant Investment LP0$00.00%−42,277−100.0%Sold out
Quantbot Technologies LP0$00.00%−32,735−100.0%Sold out
Capstone Investment Advisors, LLC0$00.00%−22,711−100.0%Sold out
Profund Advisors LLC0$00.00%−12,405−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−12,000−100.0%Sold out
XTX Topco Ltd0$00.00%−11,963−100.0%Sold out
Geneos Wealth Management Inc.0$00.00%−3,100−100.0%Sold out
Artal Group S.A.0$00.00%−1,490−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−162−100.0%Sold out
CWM, LLC0$00.00%−7−100.0%Sold out
CHI Advisors LLC––––Not filed